In an interview with pharmaphorum, Marius Scholtz, country medical lead for Roche UK, said the drug will have around the same yearly cost in relapsing disease as Novartis’ once-daily pill ...

The Danish company’s share price rise of 7 per cent this year lags far behind its rival Eli Lilly’s 36 per cent, as the US company has gradually increased its share of the obesity and diabetes market ...

Going beyond the pill is proving to be a win/win for patients ... which was supported by Roche Diabetes Care, and delivered by accredited therapists who had been trained to understand and manage ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo ...

Trap is filmmaker M. Night Shyamalan's latest psychological thriller, which was released in the US by Warner Bros. Pictures on August 2, 2024.

Patients with rare diseases in India, like Saifullah Khalidi with spinal muscular atrophy (SMA), struggle to afford ...

Roche has a pill in mid-stage studies aimed at treating ovarian cancer, which strikes about 20,000 Americans annually. The company said it may put off seeking approval in that area until the drug is ...

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...

Medical experts have called for more health-care resources and education targeting women, children and the elderly during the ...